Viewing Study NCT00310895


Ignite Creation Date: 2025-12-24 @ 2:06 PM
Ignite Modification Date: 2025-12-28 @ 6:48 AM
Study NCT ID: NCT00310895
Status: COMPLETED
Last Update Posted: 2015-12-24
First Post: 2006-04-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor Malignancies
Sponsor: Geron Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module